On the future of genetic risk assessment
- 1 April 2012
- journal article
- research article
- Published by Springer Nature in Journal of Community Genetics
- Vol. 3 (3) , 229-236
Abstract
Next-generation sequencing (NGS) techniques have greatly accelerated the molecular elucidation of Mendelian disorders, and affordable NGS-based diagnostic tests are around the corner that promise to detect or rule out mutations in specific subsets of the known disease genes. Whole exome sequencing and shortly afterwards whole genome sequencing (WGS) will become an even more comprehensive alternative to such targeted tests. In view of the current enthusiasm to implement these methods, but also given their rapidly dropping costs, it is quite possible that WGS will soon be adopted as universal intake test in Clinical Genetics. Central databases and large-scale genotype–phenotype comparisons will be required to progressively identify the clinically relevant sequence variants and to distinguish them from neutral polymorphisms in the human genome, and these databases will become indispensable for the interpretation of individual genome sequences. In this scenario, there will be massively growing demand for genetic counselling, but the need for experienced syndromologists will not increase proportionally, as the success of the diagnostic process will become far less dependent on the ability of clinical geneticists to reliably recognize genetic syndromes.Keywords
This publication has 32 references indexed in Scilit:
- Mutations in MTFMT Underlie a Human Disorder of Formylation Causing Impaired Mitochondrial TranslationCell Metabolism, 2011
- Targeted sequencing of the human X chromosome exomeGenomics, 2011
- Target-enrichment strategies for next-generation sequencingNature Methods, 2010
- Mutation screening in 86 known X-linked mental retardation genes by droplet-based multiplex PCR and massive parallel sequencingThe HUGO Journal, 2009
- Mutations inSYNGAP1in Autosomal Nonsyndromic Mental RetardationNew England Journal of Medicine, 2009
- Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencingNature Biotechnology, 2009
- Accurate whole human genome sequencing using reversible terminator chemistryNature, 2008
- The complete genome of an individual by massively parallel DNA sequencingNature, 2008
- Genome-wide in situ exon capture for selective resequencingNature Genetics, 2007
- New Perspectives for the Elucidation of Genetic DisordersThe American Journal of Human Genetics, 2007